戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ith maximal effects on PKA noted at 10(-12)M peptide T.
2 before and one after 12 wk of treatment with peptide T.
3                       Using five SPPs (SPACE peptide, TD-1, polyarginine, a dermis-localizing peptide
4 essed the potential of the fusion inhibitory peptide T-1249 for development as a vaginal microbicide
5                        The fusion inhibitory peptide T-20 contains an additional tryptophan-rich sequ
6                                The synthetic peptide T-20, which corresponds to a sequence within the
7 de receptor by f-met-leu-phe and HIV-derived peptide T-20-suppressed IL-12 p70 production from human
8 mino acid substitutions within the synthetic peptide T(249)-F(260), identified a major role for R(250
9 ormation, is different from that of a longer peptide, T(40), corresponding to the entire 40-amino aci
10  or no Ab response could be detected against peptides t alpha 182-198 or t alpha 146-162 itself.
11                                   The D-Ala1-peptide T-amide (DAPTA) peptide was selected as a target
12 intestinal peptide (VIP) and DAPTA (D-ala(1)-peptide T-amide, a gp120-derived octapeptide homologous
13           Because treatment of patients with peptide T (an octapeptide sequence found in the human im
14                  These results indicate that peptide T and gp120 protein may inversely alter the intr
15 tion, studies were initiated to determine if peptide T and gp120 protein treatment of normal and psor
16                              The presence of peptide T blocked this effect of the gp120 protein.
17  crystal x-ray diffraction for the synthetic peptide t-butoxycarbonyl--beta-Phe-beta-Phe-D-Pro-Gly-be
18 lem, we tested whether covalently coupling a peptide T cell determinant, OVA(323-339), to transferrin
19  immunologists is finding matches for linear peptide T cell epitopes, typically between 8 and 15 resi
20 tumor-associated Ags and their corresponding peptide T cell epitopes.
21 strate a previously unrecognized mode of MHC-peptide-T cell receptor interaction.
22 used to define structural aspects of the MHC/peptide/T cell receptor interaction and to study the sig
23 l and functional characterization of the MHC/peptide/T cell receptor recognition unit.
24 edict splicing-derived immunogenic MHC-bound peptides (T cell antigen) and unannotated transmembrane
25       Allergen immunotherapy using synthetic peptide T-cell epitopes (Cat-PAD) from the major cat all
26 ity for DQ0602 molecules than the VP16 33-52 peptide, T cells that recognized the VP16 369-380 peptid
27 e from the interactions among populations of peptides, T cells and MHC molecules?
28                       In naturally processed peptides, T cells only recognize posttranslationally alt
29  Furthermore, the putative gp120 antagonist, Peptide T (DAPTA), prevented the suppression of GH by gp
30   Treatment of normal human fibroblasts with peptide T did not result in any change in PKA levels.
31                                              Peptide T exhibited a biphasic dose dependent response,
32                           The phage-selected peptide t(F)2 has three of the four amino acids crucial
33                                              Peptide t(F)2's higher affinity for the ASL(Phe)-Cm(32),
34                One of the peptides selected, peptide t(F)2, exhibited the highest specificity and mos
35 osed of the immunoadjuvant Pam(3)CysSK(4), a peptide T(helper) epitope and an aberrantly glycosylated
36                                              Peptide T is an octapeptide under investigation for trea
37                                Together with peptides, T lymphocytes respond to hydrophobic molecules
38 was considerably less stable than the parent peptide (T(m) = 30 degrees C).
39 ightly more thermally stable than the parent peptide (T(m) = 37 vs 34 degrees C), while the peptide c
40 n the melting temperatures of the other four peptides (T(m) approximately 346-350 K).
41 for the Arg-, Val-, Glu-, and Asp-containing peptides, T(m) < 0 degrees C.
42 d with TAT (transactivator of transcription) peptide (T-NPs) as an example to investigate their impac
43 tment protocol with 1.2 mg/day of intranasal peptide T, one before and one after 12 wk of treatment w
44         Exposure of psoriatic fibroblasts to peptide T resulted in a time (4 h to 6 d) and dose [10(-
45 insight into the noted beneficial effects of peptide T treatment, including an improvement in psoriat